Carbachols Headache-inducing Effect and Changes in Cerebral Blood Flow in Migraine Patients
NCT ID: NCT00564408
Last Updated: 2009-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2007-08-31
2009-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Carbachol´s Headache Inducing Characteristics and Effects on the Cerebral Blood Flow
NCT00357864
Headache Inducing Effect of Cromakalim in Migraine Patients
NCT03228355
The Hemodynamic Effects of CGRP After Glibenclamide Administration in Healthy Volunteers
NCT04231617
Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.
NCT00358839
CGRP-induced Migraine Attacks in Patients Who Have Tried Anti-CGRP Monoclonal Antibody Treatment
NCT03481400
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
I
Carbachol
3 microgram per kg bodyweight infused intravenously
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Carbachol
3 microgram per kg bodyweight infused intravenously
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Weight 50-100 kg
Exclusion Criteria
* Migraine 5 days prior to experiment
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danish Headache Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Danish HC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Henrik Schytz, MD
Role: PRINCIPAL_INVESTIGATOR
Danish Headache Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Danish Headache Center
Glostrup Municipality, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HC20070049
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.